Loading…

Relationships with serum parathyroid hormone in old institutionalized subjects

OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefor...

Full description

Saved in:
Bibliographic Details
Published in:Clinical endocrinology (Oxford) 2001-05, Vol.54 (5), p.583-592
Main Authors: Stein, M. S., Flicker, L., Scherer, S. C., Paton, L. M., O'Brien, M. L., Walton, S. C., Chick, P., Di Carlantonio, M., Zajac, J. D., Wark, J. D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3
cites cdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3
container_end_page 592
container_issue 5
container_start_page 583
container_title Clinical endocrinology (Oxford)
container_volume 54
creator Stein, M. S.
Flicker, L.
Scherer, S. C.
Paton, L. M.
O'Brien, M. L.
Walton, S. C.
Chick, P.
Di Carlantonio, M.
Zajac, J. D.
Wark, J. D.
description OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents. DESIGN Cross‐sectional analysis. PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years. MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide. RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype. CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium.
doi_str_mv 10.1046/j.1365-2265.2001.01182.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70878997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70878997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</originalsourceid><addsrcrecordid>eNqNkUuP0zAURi0EYsrAX0ARSOwSruP4tWCBqmFmxFAEArG0nNhWHfIodqJp-fXj0KpIrFhdyz7nXvszQhmGAkPF3rYFJozmZcloUQLgAjAWZbF_hFbng8doBQQgB8aqC_QsxhYAqAD-FF1gTARUQqzQ5qvt9OTHIW79Lmb3ftpm0Ya5z3Y66Gl7CKM32XYM_TjYzA_Z2JlU4uSnedF0539bk8W5bm0zxefoidNdtC9O9RJ9_3D1bX2T332-vl2_v8ubiooyp445QitSGlwbbmpdC6tdrQ3DFSXgQDJNa9NocDw9jRjZpF1jJKe8ctKQS_Tm2HcXxl-zjZPqfWxs1-nBjnNUHAQXUvIEvvoHbMc5pGtHhWViSiZkgsQRasIYY7BO7YLvdTgoDGoJXLVqyVUtuaolcPUncLVP6stT_7nurfkrnhJOwOsToGOjOxf00Ph45iQv0_8k6t2RuvedPfz3eLW-2iyr5OdH38fJ7s--Dj8V44RT9WNzrT7i9c3mk2DqC3kA8USroQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198782689</pqid></control><display><type>article</type><title>Relationships with serum parathyroid hormone in old institutionalized subjects</title><source>Wiley</source><creator>Stein, M. S. ; Flicker, L. ; Scherer, S. C. ; Paton, L. M. ; O'Brien, M. L. ; Walton, S. C. ; Chick, P. ; Di Carlantonio, M. ; Zajac, J. D. ; Wark, J. D.</creator><creatorcontrib>Stein, M. S. ; Flicker, L. ; Scherer, S. C. ; Paton, L. M. ; O'Brien, M. L. ; Walton, S. C. ; Chick, P. ; Di Carlantonio, M. ; Zajac, J. D. ; Wark, J. D.</creatorcontrib><description>OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents. DESIGN Cross‐sectional analysis. PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years. MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide. RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype. CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium.</description><identifier>ISSN: 0300-0664</identifier><identifier>EISSN: 1365-2265</identifier><identifier>DOI: 10.1046/j.1365-2265.2001.01182.x</identifier><identifier>PMID: 11380488</identifier><identifier>CODEN: CLECAP</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Aged ; Aged, 80 and over ; Benzothiadiazines ; Biological and medical sciences ; Body Weight ; Cross-Sectional Studies ; Diuretics ; Endocrinopathies ; Female ; Furosemide - therapeutic use ; Genotype ; Hip Fractures - etiology ; Homes for the Aged ; Humans ; Hydroxycholecalciferols - blood ; Hyperparathyroidism, Secondary - complications ; Hyperparathyroidism, Secondary - diagnosis ; Institutionalization ; Linear Models ; Male ; Medical sciences ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Nursing Homes ; Parathyroid Hormone - blood ; Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) ; Phosphates - blood ; Receptors, Calcitriol - genetics ; Risk Factors ; Sodium Chloride Symporter Inhibitors - therapeutic use ; Tropical medicine</subject><ispartof>Clinical endocrinology (Oxford), 2001-05, Vol.54 (5), p.583-592</ispartof><rights>2001 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. May 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</citedby><cites>FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=972664$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11380488$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stein, M. S.</creatorcontrib><creatorcontrib>Flicker, L.</creatorcontrib><creatorcontrib>Scherer, S. C.</creatorcontrib><creatorcontrib>Paton, L. M.</creatorcontrib><creatorcontrib>O'Brien, M. L.</creatorcontrib><creatorcontrib>Walton, S. C.</creatorcontrib><creatorcontrib>Chick, P.</creatorcontrib><creatorcontrib>Di Carlantonio, M.</creatorcontrib><creatorcontrib>Zajac, J. D.</creatorcontrib><creatorcontrib>Wark, J. D.</creatorcontrib><title>Relationships with serum parathyroid hormone in old institutionalized subjects</title><title>Clinical endocrinology (Oxford)</title><addtitle>Clin Endocrinol (Oxf)</addtitle><description>OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents. DESIGN Cross‐sectional analysis. PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years. MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide. RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype. CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Benzothiadiazines</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Cross-Sectional Studies</subject><subject>Diuretics</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Furosemide - therapeutic use</subject><subject>Genotype</subject><subject>Hip Fractures - etiology</subject><subject>Homes for the Aged</subject><subject>Humans</subject><subject>Hydroxycholecalciferols - blood</subject><subject>Hyperparathyroidism, Secondary - complications</subject><subject>Hyperparathyroidism, Secondary - diagnosis</subject><subject>Institutionalization</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Nursing Homes</subject><subject>Parathyroid Hormone - blood</subject><subject>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</subject><subject>Phosphates - blood</subject><subject>Receptors, Calcitriol - genetics</subject><subject>Risk Factors</subject><subject>Sodium Chloride Symporter Inhibitors - therapeutic use</subject><subject>Tropical medicine</subject><issn>0300-0664</issn><issn>1365-2265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqNkUuP0zAURi0EYsrAX0ARSOwSruP4tWCBqmFmxFAEArG0nNhWHfIodqJp-fXj0KpIrFhdyz7nXvszQhmGAkPF3rYFJozmZcloUQLgAjAWZbF_hFbng8doBQQgB8aqC_QsxhYAqAD-FF1gTARUQqzQ5qvt9OTHIW79Lmb3ftpm0Ya5z3Y66Gl7CKM32XYM_TjYzA_Z2JlU4uSnedF0539bk8W5bm0zxefoidNdtC9O9RJ9_3D1bX2T332-vl2_v8ubiooyp445QitSGlwbbmpdC6tdrQ3DFSXgQDJNa9NocDw9jRjZpF1jJKe8ctKQS_Tm2HcXxl-zjZPqfWxs1-nBjnNUHAQXUvIEvvoHbMc5pGtHhWViSiZkgsQRasIYY7BO7YLvdTgoDGoJXLVqyVUtuaolcPUncLVP6stT_7nurfkrnhJOwOsToGOjOxf00Ph45iQv0_8k6t2RuvedPfz3eLW-2iyr5OdH38fJ7s--Dj8V44RT9WNzrT7i9c3mk2DqC3kA8USroQ</recordid><startdate>200105</startdate><enddate>200105</enddate><creator>Stein, M. S.</creator><creator>Flicker, L.</creator><creator>Scherer, S. C.</creator><creator>Paton, L. M.</creator><creator>O'Brien, M. L.</creator><creator>Walton, S. C.</creator><creator>Chick, P.</creator><creator>Di Carlantonio, M.</creator><creator>Zajac, J. D.</creator><creator>Wark, J. D.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200105</creationdate><title>Relationships with serum parathyroid hormone in old institutionalized subjects</title><author>Stein, M. S. ; Flicker, L. ; Scherer, S. C. ; Paton, L. M. ; O'Brien, M. L. ; Walton, S. C. ; Chick, P. ; Di Carlantonio, M. ; Zajac, J. D. ; Wark, J. D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Benzothiadiazines</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Cross-Sectional Studies</topic><topic>Diuretics</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Furosemide - therapeutic use</topic><topic>Genotype</topic><topic>Hip Fractures - etiology</topic><topic>Homes for the Aged</topic><topic>Humans</topic><topic>Hydroxycholecalciferols - blood</topic><topic>Hyperparathyroidism, Secondary - complications</topic><topic>Hyperparathyroidism, Secondary - diagnosis</topic><topic>Institutionalization</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Nursing Homes</topic><topic>Parathyroid Hormone - blood</topic><topic>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</topic><topic>Phosphates - blood</topic><topic>Receptors, Calcitriol - genetics</topic><topic>Risk Factors</topic><topic>Sodium Chloride Symporter Inhibitors - therapeutic use</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stein, M. S.</creatorcontrib><creatorcontrib>Flicker, L.</creatorcontrib><creatorcontrib>Scherer, S. C.</creatorcontrib><creatorcontrib>Paton, L. M.</creatorcontrib><creatorcontrib>O'Brien, M. L.</creatorcontrib><creatorcontrib>Walton, S. C.</creatorcontrib><creatorcontrib>Chick, P.</creatorcontrib><creatorcontrib>Di Carlantonio, M.</creatorcontrib><creatorcontrib>Zajac, J. D.</creatorcontrib><creatorcontrib>Wark, J. D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical endocrinology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stein, M. S.</au><au>Flicker, L.</au><au>Scherer, S. C.</au><au>Paton, L. M.</au><au>O'Brien, M. L.</au><au>Walton, S. C.</au><au>Chick, P.</au><au>Di Carlantonio, M.</au><au>Zajac, J. D.</au><au>Wark, J. D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationships with serum parathyroid hormone in old institutionalized subjects</atitle><jtitle>Clinical endocrinology (Oxford)</jtitle><addtitle>Clin Endocrinol (Oxf)</addtitle><date>2001-05</date><risdate>2001</risdate><volume>54</volume><issue>5</issue><spage>583</spage><epage>592</epage><pages>583-592</pages><issn>0300-0664</issn><eissn>1365-2265</eissn><coden>CLECAP</coden><abstract>OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents. DESIGN Cross‐sectional analysis. PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years. MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide. RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype. CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11380488</pmid><doi>10.1046/j.1365-2265.2001.01182.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-0664
ispartof Clinical endocrinology (Oxford), 2001-05, Vol.54 (5), p.583-592
issn 0300-0664
1365-2265
language eng
recordid cdi_proquest_miscellaneous_70878997
source Wiley
subjects Aged
Aged, 80 and over
Benzothiadiazines
Biological and medical sciences
Body Weight
Cross-Sectional Studies
Diuretics
Endocrinopathies
Female
Furosemide - therapeutic use
Genotype
Hip Fractures - etiology
Homes for the Aged
Humans
Hydroxycholecalciferols - blood
Hyperparathyroidism, Secondary - complications
Hyperparathyroidism, Secondary - diagnosis
Institutionalization
Linear Models
Male
Medical sciences
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Nursing Homes
Parathyroid Hormone - blood
Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)
Phosphates - blood
Receptors, Calcitriol - genetics
Risk Factors
Sodium Chloride Symporter Inhibitors - therapeutic use
Tropical medicine
title Relationships with serum parathyroid hormone in old institutionalized subjects
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A34%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationships%20with%20serum%20parathyroid%20hormone%20in%20old%20institutionalized%20subjects&rft.jtitle=Clinical%20endocrinology%20(Oxford)&rft.au=Stein,%20M.%20S.&rft.date=2001-05&rft.volume=54&rft.issue=5&rft.spage=583&rft.epage=592&rft.pages=583-592&rft.issn=0300-0664&rft.eissn=1365-2265&rft.coden=CLECAP&rft_id=info:doi/10.1046/j.1365-2265.2001.01182.x&rft_dat=%3Cproquest_cross%3E70878997%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=198782689&rft_id=info:pmid/11380488&rfr_iscdi=true